GLP-1 levels can fluctuate based on food intake and timing
Intriguingly, GOS upregulated IL-10 more effectively than Citalopram, a selective serotonin reuptake inhibitor (Miranda et al., 2025) highlighting its therapeutic promise via the MGBA pathway
This competitive binding may offer advantages over covalent inhibition by enhancing specificity and reducing the risk of non-specific interactions, which can limit covalent inhibitors therapeutic use
conversely, infusion of PYY [136] inhibits food intake in wild-type but not in Fischer 344 rats with an inactivating point mutation in the Dpp4 gene (121)
Medication delivered If eligible, medication ships directly to patients door
Ethics declarations Ethics approval and consent to participate The animal protocol for this study was approved by the Institutional Animal Care and Use Committee of Huazhong Agricultural University, China (HZAURA-2025-0001)